Resultados: 4

A multiphase program for malaria elimination in southern Mozambique (the Magude project): A before-after study

PloS med; 17 (8), 2020
Background: Malaria eradication remains the long-term vision of the World Health Organization (WHO). However, whether malaria elimination is feasible in areas of stable transmission in sub-Saharan Africa with currently available tools remains a subject of debate. This study aimed to evaluate a multiphase...

Saberes sobre a malária: um estudo qualitativo baseado no Distrito do Lago, Província de Niassa (Moçambique – África)
Knowledge about malaria: a qualitative study based in the District of Lago District, Niassa Province (Mozambique - Africa)

Vittalle; 32 (3), 2020
Em Moçambique a malária é responsável por 60% de todas as admissões pediátricas, por 40% do total de consultas e ainda por 30% de todas as mortes registadas nos hospitais (2).Com vista a reverter esse cenário, o governo moçambicano, por intermédio do Programa Nacional de Combate à Malária (PCN...

Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities

BMC med; 15 (1), 2017
Resistance and tolerance to Plasmodium falciparum can determine the progression of malaria disease. However, quantitative evidence of tolerance is still limited. We investigated variations in the adverse impact of P. falciparum infections among African pregnant women under different intensities of malari...

RTS, S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection

PLoS clin. trials; 1 (5), 2006
The candidate malaria vaccine RTS,S/AS02A is a recombinant protein containing part of the circumsporozoite protein (CSP) sequence of Plasmodium falciparum, linked to the hepatitis B surface antigen and formulated in the proprietary adjuvant system AS02A. In a recent trial conducted in children younger th...